European stocks recovered from a two-week low on Monday (August 24)...
Investors were boosted by signs of progress in developing a treatment for the new coronavirus.
On Sunday (August 23), the U.S. health regulator said it authorized the use of blood plasma from patients who had recovered as a treatment.
That helped offset fears about a resurgence in virus cases across Europe that could hurt any economic recovery.
The pan-European STOXX 600 rose around 1.5% in early trade.
Those gains followed Asian markets, which also went up across the board on the back of the treatment update.
Technology, mining and chemical companies led the surge in European trading.
Pharma giant AstraZeneca was up close to 3%.
It comes after Britain's Financial Times reported the Trump administration was considering fast-tracking an experimental vaccine the company is developing.
Monday's gains are a positive start, especially following last week's disappointing showing, when data pointed to business recovery stalling in the euro zone as virus cases surged.
Elsewhere, British telecoms firm BT was a standout performer on the STOXX 600, up around 4% by mid morning.
Media reports said its board was prepared to defend the company against takeover approaches from rivals and buyout firms.